Qualitative disorder measurements from backscattering spectra through an optical fiber.


Journal

Biomedical optics express
ISSN: 2156-7085
Titre abrégé: Biomed Opt Express
Pays: United States
ID NLM: 101540630

Informations de publication

Date de publication:
01 Oct 2020
Historique:
received: 23 04 2020
revised: 19 09 2020
accepted: 19 09 2020
entrez: 5 11 2020
pubmed: 6 11 2020
medline: 6 11 2020
Statut: epublish

Résumé

In the processes related to the development of cancer, there are different genetic and epigenetic events involved that result in structural changes of the affected cells. In the early stages of the disease, these changes occur at the nanoscale, remaining undetectable by conventional light microscopy, due to diffraction-limited resolution (∼250 - 550 nm). In this sense, a technique termed partial wave spectroscopy (PWS) allows the detection of these nanostructural changes by measuring a statistical parameter called disorder strength (

Identifiants

pubmed: 33150004
doi: 10.1364/BOE.396013
pii: 396013
pmc: PMC7587252
doi:

Types de publication

Journal Article

Langues

eng

Pagination

6038-6048

Informations de copyright

© 2020 Optical Society of America under the terms of the OSA Open Access Publishing Agreement.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest related to this article.

Références

PLoS One. 2017 May 31;12(5):e0176839
pubmed: 28562683
Opt Lett. 2005 Sep 15;30(18):2445-7
pubmed: 16196347
Sci Rep. 2017 Feb 23;7:43025
pubmed: 28230204
PLoS One. 2013 May 28;8(5):e64600
pubmed: 23724067
Hum Pathol. 1998 Dec;29(12):1403-11
pubmed: 9865825
Biomed Opt Express. 2016 Aug 31;7(9):3795-3810
pubmed: 27699138
Cancer Cell Int. 2007 Mar 15;7:2
pubmed: 17362521
Cancer Med. 2018 May;7(5):2109-2120
pubmed: 29573208
Biophys J. 2010 Aug 4;99(3):989-96
pubmed: 20682278
BMC Cancer. 2014 Mar 14;14:189
pubmed: 24629088
Phys Rev B Condens Matter. 1994 Oct 1;50(13):9644-9647
pubmed: 9975033
Hum Pathol. 1988 Mar;19(3):304-8
pubmed: 2831134
Front Pharmacol. 2018 Feb 06;9:80
pubmed: 29467660
Clin Cancer Res. 2002 Feb;8(2):314-46
pubmed: 11839647
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20118-23
pubmed: 19073935
Opt Lett. 2009 Feb 15;34(4):518-20
pubmed: 19373360
Mod Pathol. 2015 Jan;28(1):14-29
pubmed: 24925058
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6372-E6381
pubmed: 27702891
Cancer. 1953 Sep;6(5):963-8
pubmed: 13094644

Auteurs

R Fernández (R)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
I.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Alicante, Spain.

A Marcos-Vidal (A)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.

S Gallego (S)

I.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Alicante, Spain.

A Beléndez (A)

I.U. Física Aplicada a las Ciencias y las Tecnologías, Universidad de Alicante, Alicante, Spain.

M Desco (M)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Mara nón, Madrid, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Spain.
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Madrid, Spain.

J Ripoll (J)

Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Madrid, Spain.
Instituto de Investigación Sanitaria Gregorio Mara nón, Madrid, Spain.

Classifications MeSH